# Apotex 預計以每股 20 至 24 美元的價格，出售 4,170 萬至 5,000 萬股。

*fintech, biotech · news · 2026-06-01 · Bnn Bloomberg*

## Key points

- Apotex Health Corp. 計劃透過首次公開募股籌集約 10 億美元。
- 將在庫藏股發行中出售 3,540 萬至 4,250 萬股，價值 8.5 億美元。
- 次級發行將包括現有股東出售的 625 萬至 750 萬股，總計 1.5 億美元。
- 出售股東可能授予承銷商最多 750 萬股的超額配售選擇權。

TORONTO — Drug company Apotex Health Corp. says it is looking to sell about $1 billion worth of shares in its initial public offering. The company says it expects to sell between 41.7 million and 50 million shares at a price between $20 and $24 per share. The plan includes the sale of between 35.4 million and 42.5 million shares in a treasury offering by the company valued at a total of about $850 million. It also includes a secondary offering of between 6.25 million and 7.5 million shares by certain shareholders valued at a total of about $150 million. The selling shareholders are also expected to grant an over-allotment option to the underwriters for up to an additional 6.25 million to 7.5 million shares at the offering price Apotex, which has applied to list the shares on the Toronto Stock Exchange, has a broad portfolio of generic drugs and consumer health products. This report by The Canadian Press was first published June 1, 2026. The Canadian Press

**Companies:** Apotex Health Corp.
**Countries:** Canada

[Read the full story on Bnn Bloomberg](https://www.bnnbloomberg.ca/business/2026/06/01/apotex-looking-to-sell-about-1-billion-in-shares-in-initial-public-offering/)

---

Canonical: https://newsio.io/zh-TW/n/af7443a8-5771-427d-a064-5c2299353434/apotex-20-24-4170-5000-3540-4250
Summarized by Newsio from Bnn Bloomberg. https://newsio.io/how-it-works